Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Cardiomyopathies D009202 10 associated lipids
Retinal Detachment D012163 10 associated lipids
Influenza, Human D007251 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Lung Injury D055370 14 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Tuberculosis D014376 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Sarcoma 180 D012510 21 associated lipids
Anemia D000740 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Zhang W et al. Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells. 2013 Prostaglandins Other Lipid Mediat. pmid:23770055
Cinq-Frais C et al. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1. 2013 Biochim. Biophys. Acta pmid:23651497
Christoffersen C and Nielsen LB Apolipoprotein M: bridging HDL and endothelial function. 2013 Curr. Opin. Lipidol. pmid:23652568
Finley A et al. Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. 2013 PLoS ONE pmid:23372844
Barth BM et al. Gaucher's disease and cancer: a sphingolipid perspective. 2013 Crit Rev Oncog pmid:23510065
Takuwa Y et al. Sphingosine-1-phosphate signaling in physiology and diseases. 2012 Sep-Oct Biofactors pmid:22674845
Iwaki S et al. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22819712
Fournie P et al. Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. 2012 Mar-Apr Indian J Ophthalmol pmid:22446906
Tse KW et al. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. 2012 Jan-Feb Cell. Immunol. pmid:22507871
Jin YX et al. A strategy for enrichment of the bioactive sphingoid base-1-phosphates produced by Hypericum perforatum L. in a balloon type airlift reactor. 2012 Bioresour. Technol. pmid:22940331
Snider AJ et al. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. 2012 Prostaglandins Other Lipid Mediat. pmid:22940715
Moon MH et al. Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. 2012 Int. J. Mol. Med. pmid:22992945
Park TS and Goldberg IJ Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. 2012 Heart Fail Clin pmid:22999245
Ihlefeld K et al. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. 2012 Biochem. J. pmid:22908849
Wang ZY et al. [Effect of sphingosine 1-phosphate/sphingosine 1-phosphate receptor signal pathway on function of neutrophils]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22931670
Cannon RE et al. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22949658
Richerioux N et al. Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease Virus. 2012 PLoS ONE pmid:22952878
He S et al. Self-amplification mechanisms of mast cell activation: a new look in allergy. 2012 Curr. Mol. Med. pmid:22920722
Hisano Y et al. The functional roles of S1P in immunity. 2012 J. Biochem. pmid:22923732
Hisano Y et al. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. 2012 PLoS ONE pmid:22723910
Chiba K and Yoshii N [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis]. 2012 Nippon Yakurigaku Zasshi pmid:22728990
Linke B et al. Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation. 2012 Prostaglandins Other Lipid Mediat. pmid:22732087
Yokoyama K et al. Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. 2012 Clin. Nephrol. pmid:22732343
Czarnota GJ et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22778441
Boussommier-Calleja A et al. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22807298
Kharel Y et al. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. 2012 Biochem. J. pmid:22747486
Sun DF et al. Sphingosine 1-phosphate antagonizes the effect of all-trans retinoic acid (ATRA) in a human colon cancer cell line by modulation of RARβ expression. 2012 Cancer Lett. pmid:22261335
Zhang BL et al. Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of constitutively active G protein-coupled receptors. 2012 J Zhejiang Univ Sci B pmid:22761247
Kotelevets N et al. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis. 2012 PLoS ONE pmid:22761740
Nakahara T et al. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. 2012 Fertil. Steril. pmid:22763095
Lu H et al. Senescent endothelial dysfunction is attributed to the up-regulation of sphingosine-1-phosphate receptor-2 in aged rats. 2012 Mol. Cell. Biochem. pmid:22139303
Fujii Y et al. Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities. 2012 J. Immunol. pmid:22131329
Ishimaru N et al. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. 2012 Am. J. Pathol. pmid:22067914
Lucki NC et al. Sphingosine-1-phosphate rapidly increases cortisol biosynthesis and the expression of genes involved in cholesterol uptake and transport in H295R adrenocortical cells. 2012 Mol. Cell. Endocrinol. pmid:21864647
Shi Y et al. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. 2012 J. Hepatol. pmid:21756852
Spiegel S et al. Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. 2012 Oncogene pmid:21725353
Krishna SM et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. 2012 Am. J. Pathol. pmid:22698985
Lee SH et al. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. 2012 J. Clin. Endocrinol. Metab. pmid:22679064
Ponnusamy S et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. 2012 EMBO Mol Med pmid:22707406
Kunisawa J and Kiyono H Immunological function of sphingosine 1-phosphate in the intestine. 2012 Nutrients pmid:22666543
Yang J et al. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling. 2012 Circulation pmid:22668972
Li C et al. Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor. 2012 J. Neurophysiol. pmid:22673325
Watson L et al. Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. 2012 J. Clin. Immunol. pmid:22648459
Sato C et al. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. 2012 Biochem. Biophys. Res. Commun. pmid:22659743
Farahat WA et al. Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures. 2012 PLoS ONE pmid:22662145
Somers SJ et al. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. 2012 Cardiovasc Drugs Ther pmid:22392184
Chakraborty G et al. Ethanol triggers sphingosine 1-phosphate elevation along with neuroapoptosis in the developing mouse brain. 2012 J. Neurochem. pmid:22393932
Beech DJ Integration of transient receptor potential canonical channels with lipids. 2012 Acta Physiol (Oxf) pmid:21624095
Belvitch P and Dudek SM Role of FAK in S1P-regulated endothelial permeability. 2012 Microvasc. Res. pmid:21925517
Karmouty-Quintana H et al. Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:22287614
Egom EE A therapeutic approach to hyperglycaemia in the setting of acute myocardial infarction: spotlight on glucagon-like peptide 1. 2012 Ther Adv Cardiovasc Dis pmid:22902834
Liu Q et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. 2012 PLoS ONE pmid:22848628
Asghar MY et al. Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. 2012 Endocr. Relat. Cancer pmid:22889737
Kim BJ et al. Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women. 2012 J. Clin. Endocrinol. Metab. pmid:22879631
Knapp M et al. Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat. 2012 Lipids pmid:22833182
Beckham TH et al. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. 2012 Int. J. Cancer pmid:22322590
Törnquist K Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. 2012 Acta Physiol (Oxf) pmid:21338471
Brizuela L et al. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. 2012 Mol. Cancer Ther. pmid:22784711
Salata D et al. [Sphingosine-1-phosphate--molecular maestro]. 2012 Postepy Biochem. pmid:23373414
Japtok L et al. Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. 2012 PLoS ONE pmid:23145172
Härmä V et al. Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. 2012 Oncogene pmid:21996742
Zhang L et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. 2012 J. Exp. Med. pmid:23148237
Qiao Y et al. Sphingosine 1-phosphate elicits proinflammatory responses in ARPE-19 cells. 2012 Invest. Ophthalmol. Vis. Sci. pmid:23150617
Mendoza A et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. 2012 Cell Rep pmid:23103166
Kurek K et al. [Role of sphingolipids in digestive system]. 2012 Postepy Hig Med Dosw (Online) pmid:23175343
Bieberich E It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation. 2012 Neurochem. Res. pmid:22246226
Wilkerson BA et al. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. 2012 J. Biol. Chem. pmid:23135269
Giacomini MM et al. Epithelial cells utilize cortical actin/myosin to activate latent TGF-β through integrin α(v)β(6)-dependent physical force. 2012 Exp. Cell Res. pmid:22309779
Visentin B et al. Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples. 2012 Methods Mol. Biol. pmid:22528439
Obinata H and Hla T Assessment of sphingosine-1-phosphate activity in biological samples by receptor internalization and adherens junction formation. 2012 Methods Mol. Biol. pmid:22528440
Medlin MD et al. Quantifying sphingosine-1-phosphate-dependent activation of the RhoGTPases. 2012 Methods Mol. Biol. pmid:22528442
Belmonte SA and Suhaiman L Optimized protocols to analyze sphingosine-1-phosphate signal transduction pathways during acrosomal exocytosis in human sperm. 2012 Methods Mol. Biol. pmid:22528443
Ishii T et al. Use of intravital microscopy and in vitro chemotaxis assays to study the roles of sphingosine-1-phosphate in bone homeostasis. 2012 Methods Mol. Biol. pmid:22528444
Meacci E et al. Sphingosine-1-phosphate signaling in skeletal muscle cells. 2012 Methods Mol. Biol. pmid:22528446
Yonesu K and Nara F [Anti-angiogenic effect of bioactive lipid antagonists]. 2012 Nippon Rinsho pmid:23513926
Wong RC et al. Maintenance of human embryonic stem cells by sphingosine-1-phosphate and platelet-derived growth factor. 2012 Methods Mol. Biol. pmid:22528447
Bieberich E Ceramide and sphingosine-1-phosphate signaling in embryonic stem cell differentiation. 2012 Methods Mol. Biol. pmid:22528448
Callihan P and Hooks SB Sphingosine-1-phosphate signaling in neural progenitors. 2012 Methods Mol. Biol. pmid:22528449
Su SC and Bayless KJ Utilizing sphingosine-1-phosphate to stimulate sprouting angiogenesis. 2012 Methods Mol. Biol. pmid:22528450
Lim M et al. The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries. 2012 PLoS ONE pmid:22532844
Lynch KR Building a better sphingosine kinase-1 inhibitor. 2012 Biochem. J. pmid:22533672
Mann DL Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. 2012 Circulation pmid:22534620
Reina E et al. Determination of sphingosine-1-phosphate lyase activity by gas chromatography coupled to electron impact mass spectrometry. 2012 Chem. Phys. Lipids pmid:22265672
Ding R et al. Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase. 2012 Inflammation pmid:21302134
Meissner A et al. Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure. 2012 Circulation pmid:22534621
Christopherson KW PBSCs Sphingoling along S1P/S1P1 axis. 2012 Blood pmid:22262738
Fujii Y et al. Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P. 2012 Biochim. Biophys. Acta pmid:22265714
Dakroub Z and Kreydiyyeh SI Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells. 2012 J. Cell. Biochem. pmid:22271589
Santulli P et al. Sphingosine pathway deregulation in endometriotic tissues. 2012 Fertil. Steril. pmid:22277765
Golan K et al. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. 2012 Blood pmid:22279055
Jiang H et al. Application of ultra-performance liquid chromatography coupled with mass spectrometry to metabonomic study on spontaneously hypertensive rats and intervention effects of Ping Gan prescription. 2012 J Sep Sci pmid:22282408
Takeshita H et al. Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis. 2012 Biochem. Biophys. Res. Commun. pmid:22326262
Shannon LA et al. CCR7/CCL19 controls expression of EDG-1 in T cells. 2012 J. Biol. Chem. pmid:22334704
Nunes J et al. Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. 2012 Br. J. Cancer pmid:22315056
Shimizu T et al. Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22308044
Canals D et al. Protein phosphatase 1α mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase. 2012 J. Biol. Chem. pmid:22311981
Knapp M et al. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure. 2012 Adv Med Sci pmid:22296975
Nagahashi M et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. 2012 Cancer Res. pmid:22298596
Ratajczak J et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. 2012 Leukemia pmid:22343521
Mascall KS et al. Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis. 2012 J. Cell. Sci. pmid:22344262